Efficient circular RNA synthesis through Gap-DNA splint-mediated ligation

Abstract

The COVID-19 pandemic heightened interest in circular RNA (C-RNA) for RNA therapeutics, offering advantages over linear mRNAs. Circular mRNA facilitates uncapped molecule development, and C-RNAs ensure stability in RNA interference therapeutics. The synthesis method, RNA ligation, is employed in C-RNA-based therapeutics. Stable DNA–RNA hybrid constructs enable efficient RNA ligase-based circularization.